Type I collagen is a major component of the extracellular matrix, and mutations in the collagen gene cause several matrix-associated diseases. These mutant procollagens are misfolded and often aggregated in the endoplasmic reticulum (ER). Although the misfolded procollagens are potentially toxic to the cell, little is known about how they are eliminated from the ER. Here, we show that procollagen that can initially trimerize but then aggregates in the ER are eliminated by an autophagy-lysosome pathway, but not by the ER-associated degradation (ERAD) pathway. Inhibition of autophagy by specific inhibitors or RNAi-mediated knockdown of an autophagy-related gene significantly stimulated accumulation of aggregated procollagen trimers in the ER, and activation of autophagy with rapamycin resulted in reduced amount of aggregates. In contrast, a mutant procollagen which has a compromised ability to form trimers was degraded by ERAD. Moreover, we found that autophagy plays an essential role in protecting cells against the toxicity of the ERAD-inefficient procollagen aggregates. The autophagic elimination of aggregated procollagen occurs independently of the ERAD system. These results indicate that autophagy is a final cell protection strategy deployed against ER-accumulated cytotoxic aggregates that are not able to be removed by ERAD.
INTRODUCTION
The biosynthesis of secretary and membrane proteins in the endoplasmic reticulum (ER) is strictly monitored by a mechanism called ER quality control to ensure that only properly folded and assembled proteins are allowed to reach their final destination (Anelli and Sitia, 2008) . Misfolded or aberrant proteins produced by mutations or various stresses are retrotranslocated from the ER into the cytosol for degradation by the 26S proteasome after modification with polyubiquitin chains, by a process called ER-associated degradation (ERAD) (Ron and Walter, 2007) . During the ERAD process, misfolded proteins are recognized by the ER-degradation enhancing ␣-mannosidase-like protein (EDEM) that presumably targets the protein for retrotranslocation and degradation (Oda et al., 2003) . Very recently, we have shown that a supramolecular complex containing the ERresident disulfide-reductase ERdj5, which is the molecular chaperone BiP, and EDEM mediates ERAD of glycoproteins (Ushioda et al., 2008) . ERAD substrates are transferred from the ER to the cytosol as unfolded polypeptide chains through translocon channel. However, how other toxic species, such as severely aggregated proteins, are eliminated from the ER is largely unknown.
In addition to ERAD, autophagy-mediated lysosomal degradation of ER proteins has also been reported (Vembar and Brodsky, 2008) . Autophagy (macroautophagy) is a catabolic process that degrades cellular organelles, exogenous viruses, and bacteria in the cytoplasm (Klionsky, 2007; Mizushima et al., 2008) . Autophagy mainly consists of three steps: formation of an autophagosome with a double membrane, sequestration of cytoplasmic constituents, and fusion of the autophagosome with lysosomes, where encapsulated constituents are degraded by proteases. A large number of factors essential for autophagosome formation have been identified in yeast and mammals (Klionsky, 2007; Suzuki and Ohsumi, 2007) . Analyses of Atg5-null, Atg7-null or Atg7 conditional knockout mice have revealed that autophagy is indispensable for the constitutive clearance of misfolded toxic proteins in the cytosol, particularly in the CNS, liver, and heart (Komatsu et al., 2007a,b) .
Recently, Kruse et al. (2006) reported using yeast ATG6-deletion mutant that an ␣1-antitrypsin Z variant (ATZ) that accumulated in the ER was degraded via autophagy as well as ERAD, and a similar autophagy-dependent degradation of ATZ was reported in ATG5 knockout mammalian cells (Kamimoto et al., 2006) . More recently, a dysferlin mutant, which causes limb girdle muscular dystrophy type 2B, has been reported to be degraded via autophagy and ERAD (Fujita et al., 2007) . However, the molecular mechanism of autophagydependent clearance of misfolded and/or aggregated proteins that accumulate in the ER is largely unknown, and little is known about what effect autophagic clearance of toxic aggregates that accumulate in the ER has on cell survival.
Collagen is a major component of the extracellular matrix essential for supporting and organizing most tissues. Type I collagen molecule is a trimer of two pro␣1(I) chains and one pro␣2(I) chain, and triple helix formation of the collagen occurs in the ER. Mutations in the COL1A1 or COL1A2 genes, including insertions, deletions, and point mutations in the helical domains (Gajko-Galicka, 2002; Marini et al., 2007) , disrupt proper formation of the triple helix and cause severe bone fragility including osteogenesis imperfecta (OI) (Rauch and Glorieux, 2004) . Folding of procollagen requires the collagen-specific molecular chaperone Hsp47 in the ER, in addition to general ER chaperones including calnexin, BiP, Grp94, and protein disulfide isomerase (PDI; Lamande and Bateman, 1999; Nagata, 2003) . Disruption of the hsp47 gene causes embryonic lethality by 11.5 days after coitus due to defects in the formation of collagen fibrils and basement membranes (Nagai et al., 2000; Marutani et al., 2004; Matsuoka et al., 2004) . In vitro analysis using hsp47-disrupted fibroblasts revealed that triple helix formation, secretion, and processing of the N-terminal propeptide of type I collagen are impaired (Matsuoka et al., 2004; Ishida et al., 2006) . We also reported that misfolded type I collagen in Hsp47-null cells formed detergent insoluble aggregates in the ER (Ishida et al., 2006) . However, little is known about how these potentially toxic aggregates are eliminated from the ER.
Here, we have explored the fate of misfolded and insoluble procollagens that have accumulated in the ER, caused either by the disruption of the collagen-specific molecular chaperone Hsp47 or by the OI-causing mutation disrupting the triple-helical domain of the pro␣1(I) chain. We show that misfolded procollagens accumulated as aggregates in the ER cannot be removed by the ERAD, but are eliminated through autophagy. Intriguingly, inhibition of autophagy by RNAimediated knockdown resulted in increased cell death concomitant with enhanced accumulation of aggregated collagen in the ER. These observations demonstrate that autophagy exerts an essential role in cell survival against the cytotoxicity of ERAD-inefficient misfolded proteins. Furthermore, we also demonstrate that under the conditions where misfolded and detergent-insoluble procollagens are accumulated in the ER, the ERAD pathway is still available for the degradation of other misfolded proteins. Thus, for the elimination of ER-accumulated aggregates, the autophagy system appears to be independent of the ERAD system. We discuss the biological significance of autophagic clearance of misfolded proteins from the ER as an alternative protective strategy in cell survival.
MATERIALS AND METHODS

Expression Vectors
Expression vectors of pro␣1(I) chain (Stephens and Pepperkok, 2002) , green fluorescent protein (GFP)-LC3 (Kabeya et al., 2000) , ␣1-antitrypsin Null Hong Kong (NHK) variant (Hosokawa et al., 2006) , and an inactive mutant of ATG4B fused with mStrawberry, which is a variant of red fluorescence prtotein (RFP; Fujita et al., 2008) were described previously.
Cell Culture, Transfection, and Biochemical Analysis
Hsp47
ϩ/ϩ (WT) and Hsp47 Ϫ/Ϫ (KO-11 and KO-13) mouse embryonic fibroblasts were reported previously (Nagai et al., 2000) . Mov13 cells and Mov13-derived cell lines (see Supplemental Figure S1 ) were also reported previously (Lamande and Bateman, 1993; Fitzgerald et al., 1999) . Cells were cultured in DMEM supplemented with 10% fetal bovine serum (FBS), ascorbic acid (50 g/ml) and antibiotics. Cells were transfected with expression vectors using Lipofectamine LTX (Invitrogen, Carlsbad, CA) according to the manufacturer's instructions. Proteins were extracted from fibroblasts using cell extraction buffer containing 0.05 M Tris-HCl. pH 8.0, 0.15 M NaCl, 5.0 mM EDTA, 1% NP-40, and protease inhibitors [2.0 mM N-ethylmaleimide, 2.0 mM 4-(2-aminoethyl)-benzenesulfonyl fluoride, 1 g/ml leupeptin and pepstatin] at 4°C. After centrifugation (14,000 rpm, 20 min), supernatant (detergent soluble), and pellet (detergent insoluble) fractions were collected and used for Western blot analysis. Determination of protein concentration and Western blotting were performed as previously described (Ishida et al., 2006) .
Inhibitors
MG132 (Peptide Institute, Osaka, Japan), lactacystin (Kyowa Medics, Tokyo, Japan), bafilomycin A1 (Wako, Osaka, Japan), E64d (Calbiochem, San Diego, CA), pepstatin A (Sigma, St. Louis, MO), wortmannin (Calbiochem), LY294002 (Calbiochem), rapamycin (Calbiochem), and tunicamycin (Sigma) were purchased from the indicated sources.
Antibodies
Mouse monoclonal antibodies to PDI (Stressgen, Victoria, BC, Canada), GAPDH (HyTest, Turku, Finland), ubiquitin (Zymed Laboratories, San Francisco, CA), CHOP (Santa Cruz Biotechnology, Santa Cruz, CA), GFP (Roche, Indianapolis, IN), and GM130 (BD Transduction Laboratories, Franklin Lakes, NJ) were purchased from the indicated sources. Rabbit polyclonal antibodies against type I collagen (Chemicon International, Temecula, CA), BiP (Affinity BioReagents, Golden, CO), ATG5 (Sigma), LC3 (MBL, Nagoya, Japan), red fluorescent protein (RFP) (MBL), which reacts with mStrawberry, and ␣1-antitrypsin (DAKO, Glostrup, Denmark) were also purchased from the indicated sources. A rat mAb against LAMP-2 (Santa Cruz), and goat polyclonal antibody against the type I collagen ␣2(I) chain (Santa Cruz) were obtained from the indicated sources. A rabbit antibody against the C-propeptide of the type I collagen pro␣1 chain (LF41) (Fisher et al., 1995) was kindly provided by Dr. Larry W. Fisher (National Institutes of Health, Bethesda, MD). Alkaline phosphatase (AP)-conjugated anti-mouse or anti-rabbit IgG (Biosource, Nivelles, Belgium), AlexaFluor488-conjugated anti-mouse, anti-rabbit, or anti-rat IgG, and AlexaFluor546-conjugated anti-mouse or anti-rabbit IgG (Invitrogen) were used as secondary antibodies.
Immunofluorescence Microscopy
Cells were washed in PBS and fixed with 4% (wt/vol) paraformaldehyde (PFA) in PBS for 15 min. After washing three times in PBS, fixed cells were permeabilized with 0.1% (vol/vol) Triton X-100/PBS for 5 min or 50 g/ml digitonin/PBS for 5 min for LC3 staining. Nonspecific protein binding in permeabilized cells was blocked by incubation with 2% goat serum/PBS for 30 min. After incubation with specific antibodies, cells were incubated with AlexaFluor-conjugated anti-mouse, anti-rabbit, or anti-rat IgG. Fluorescent signals were analyzed by an LSM 510 META confocal laser microscope (Carl Zeiss, Jena, Germany).
Fluorescence Recovery after Photobleaching Analysis
Fluorescence recovery after photobleaching (FRAP) analysis was performed as described previously (Lippincott-Schwartz et al., 2001; Kitamura et al., 2006) . Briefly, cells were transfected with GFP-pro␣1(I) or GFP-ER as a control using Lipofectamine LTX. Before FRAP analysis, culture medium was changed from normal medium to phenol red-free medium containing 25 mM HEPES buffer (Invitrogen). Regions of the ER were bleached using a 488-nm Argon laser at 100% power through a C-Apochromat 40ϫ/1.2 NA Corr. water immersion objective using the LSM 510 META microscope at 37°C. For recovery measurements, GFP was excited with a 488-nm Argon (30 mW) laser at 1% AOTF transmission. Signals were collected through a 505-nm-long path emission filter. In control experiments, cells were fixed in PBS containing 4% (wt/vol) PFA for 1 h.
Immunoelectron Microscopy
Pre-embedding gold-enhanced immunostaining was performed as previously described (Luo et al., 2006) . Cryo-ultramicrotomy and double-immunogold staining on the cryo-ultrathin sections were carried out as described previously (Kimura et al., 2008) . Antibodies against type I collagen (Chemicon), LAMP-2 (Santa Cruz), GFP (Roche), or LC3 (MBL) were used as primary antibodies.
oligo ID 12935-300) using Lipofectamine RNAiMAX according to the manufacturer's instructions. After culture for 48 h, knockdown efficiency was determined at the RNA and protein levels. Primers used for RT-PCR analysis were GACAAAGATGTGCTTCGAGATGTG (forward) and GTA-GCTCAGATGCTCGCTCAG (reverse) for ATG5 and CAGGAGCGAGAC-CCCACTAA (forward) and GCCTGCTTCACCACCTTCTT (reverse) for GAPDH.
Metabolic Labeling and Immunoprecipitation
Cells were cultured in the presence of 4.1 MBq/ml 35 S-labeled Met and Cys (Express 35 S Protein Labeling Mixture, PerkinElmer Life Sciences, Boston, MA) containing 10% dialyzed FBS for 20 min. For pulse-chase experiments, labeled cells were chased for appropriate periods of time in medium containing excess unlabeled Met and Cys. Soluble proteins were extracted in cell extraction buffer, and antibody was added to cell extracts or culture media. Immune complexes were captured using protein A-Sepharose (GE Healthcare Bio-Sciences, Piscataway, NJ) and washed in cell extraction buffer. Proteins were extracted in SDS-PAGE sample buffer and separated by SDS-PAGE. Gels were exposed to phosphor-imaging plates and analyzed by a STORM 820 image analyzer (GE Healthcare Bio-Sciences).
Analysis of Cell Death
Apoptotic cell death was analyzed by Hoechst33342 staining as previously described (Ogata et al., 2006) . Cell counting was performed using a Biozero digital microscope (Keyence, Osaka, Japan) equipped with a PlanFluor 20ϫ, 0.50 NA objective (Nikon, Tokyo, Japan).
Statistical Analysis
Significant differences were determined by Student's t test.
RESULTS
Lysosomal Degradation of Misfolded Procollagen in Hsp47-disrupted Cells
We previously reported using Hsp47-disrupted mouse embryos and fibroblasts that type I procollagen accumulates as detergent-insoluble form in the ER because of failure to form a properly folded triple helix Ishida et al., 2006) . FRAP analysis revealed that the fluorescence recovery of GFP-pro␣1(I) in the ER of Hsp47 Ϫ/Ϫ cells decreased (ϳ65%) relative to that of Hsp47 ϩ/ϩ cells (ϳ90%; Figure 1 , A and B, and Supplemental Figure S2A ), whereas fluorescence recovery of GFP-ER, a control GFP expressed in the ER, was similar in both cell lines (Supplemental Figure  S2 , B-D). To examine whether this delay in fluorescence recovery was due to aggregate formation of procollagen in the ER of Hsp47 Ϫ/Ϫ cells, we performed a centrifugal fractionation assay followed by immunoblotting. Collagen synthesis and the level of accumulated procollagen increased when the culture became confluent, and therefore cells from confluent cultures on the third day of culture were used for the assay. Figure 1C shows that procollagens increased in the detergent-insoluble fraction of Hsp47 Ϫ/Ϫ cells but not in the detergent-insoluble fraction of Hsp47 ϩ/ϩ cells. These data strongly suggested that procollagen accumulates as immobile and detergent-insoluble aggregates in Hsp47 Ϫ/Ϫ cells. To investigate how the misfolded procollagen is eliminated from the ER, we examined possible involvement of two major degradation systems, the ubiquitin-proteasome (Hershko et al., 2000) and ubiquitin-lysosome (Luzio et al., 2007; Mizushima et al., 2008) systems. In the presence of the proteasome inhibitors, MG132 and lactacystin, overall polyubiquitination of intracellular proteins was significantly increased, indicating that these inhibitors work effectively (Supplemental Figure S3A ). Under these conditions, however, procollagen accumulation was unaffected either in Hsp47 ϩ/ϩ or Hsp47 Ϫ/Ϫ cells ( Figure 1D and Supplemental Figure S3A ). In contrast, inhibition of lysosome-mediated degradation by E64d and pepstatin A, inhibitors of lysosomal proteases including the cathepsins (Komatsu et al., 2007b) , or bafilomycin A1, a V-ATPase inhibitor (Yoshimori et al., 1991) , significantly enhanced the accumulation of insoluble procollagen in Hsp47 Ϫ/Ϫ cells, but not in Hsp47 ϩ/ϩ cells ( Figure 1E and Supplemental Figure S3B ). Pulse-chase experiments followed by immunoprecipitation demonstrated that degradation of newly synthesized procollagen was inhibited by bafilomycin A1, but not by lactacystin in Hsp47 Ϫ/Ϫ cells ( Figure 1G ). In contrast, newly synthesized procollagen in Hsp47 ϩ/ϩ cells was secreted very rapidly as described previously (Ishida et al., 2006) , and the rate was not affected by bafilomycin A1 or lactacystin ( Figure 1F ). These data clearly indicate that misfolded procollagen that accumulates in the ER due to the absence of Hsp47 is degraded by lysosomal enzymes, but not by the proteasome.
Procollagen is localized primarily in the Golgi apparatus in Hsp47 ϩ/ϩ cells, as indicated by colocalization with GM130 (Golgi marker) but not PDI (ER marker; Figure 2 , A and B). However, procollagen in Hsp47 Ϫ/Ϫ cells was localized in the ER (Figure 2 , D and E), as we previously reported (Ishida et al., 2006) . In the presence of E64d/pepstatin A, procollagen in Hsp47 Ϫ/Ϫ cells accumulated in lysosomes, as indicated by colocalization with LAMP-2, a lysosome marker ( Figure 2F ). In contrast, colocalization of procollagen with LAMP-2 was not observed in Hsp47 ϩ/ϩ cells even in the presence of E64d/pepstatin A ( Figure 2C ). It was previously reported that autophagosomes fuse with endocytotic structures such as multivesicular bodies (MVBs) to generate the amphisome, which then fuses with lysosomes (Filimonenko et al., 2007; Fader and Colombo, 2009 ). Immunoelectron microscopy revealed that procollagen in Hsp47 Ϫ/Ϫ cells was located in amphisome-like structures ( Figure 2G ). Localization of procollagen in LAMP-2-positive vesicular structures was observed by double labeling immunoelectron microscopy in Hsp47 Ϫ/Ϫ cells after E64d/pepstatin A treatment (Figure 2, H and I). These results suggest that misfolded procollagen is delivered to the lysosome via amphisome-like structures for degradation in Hsp47 Ϫ/Ϫ cells.
Autophagy Is Activated in Hsp47-Null Cells
Recently, aggregation prone proteins in the ER were reported to be degraded through autophagy as well as ERAD (Vembar and Brodsky, 2008) . To test whether the lysosomedependent degradation of misfolded collagen in Hsp47
cells is mediated by autophagy, we examined the activation of LC3, an autophagy marker . LC3 is a microtubule associated protein existing as two isoforms, LC3-I and LC3-II, in vivo. Posttranslational modification with phosphatidylethanolamine (PE) converts LC3-I to LC3-II. The LC3-II form is active in autophagosome formation and binds to the autophagosome membrane (Kabeya et al., 2000) . Immunoblotting experiments of cell extracts indicated that LC3-II was induced in Hsp47 Ϫ/Ϫ cells, but not in Hsp47 ϩ/ϩ cells ( Figure 3A ). The level of LC3-II in Hsp47
cells increased when cells were treated with lysosomal inhibitors ( Figure 3B ). Immunostaining of endogenous LC3 revealed a large number of strongly stained punctate structures in Hsp47 Ϫ/Ϫ cells ( Figure 3C ), similar to a typical autophagosome staining patterns. In contrast, a weak, diffuse cytoplasmic staining pattern was observed in Hsp47 ϩ/ϩ cells. Immunoelectron microscopy indicated that vesicular structures surrounded by LC3-positive membranes were formed in Hsp47 Ϫ/Ϫ cells ( Figure 3D ). GFP-LC3 colocalized with the membrane of early-autophagosomal structures ( Figure 3E ) when transiently transfected into Hsp47 Ϫ/Ϫ cells. Moreover, colocalization of procollagen and LC3 was observed Hsp47 Ϫ/Ϫ cells ( Figure 3F ). Taken together, these data strongly suggest that autophagy is strongly induced, and a large number of autophagosomes that contain type I procollagen aggregates are produced in Hsp47 Ϫ/Ϫ cells.
Inhibition of Autophagy Stimulates Accumulation of Misfolded Procollagen and Cell Death
To examine whether autophagic activity in Hsp47 Ϫ/Ϫ cells is required for the clearance of misfolded procollagen in the ER, cells were treated with inhibitors of autophagic activity, namely wortmannin and LY294002. These substances inhibit autophagosome formation by inhibiting phosphatidylinositol 3Ј-kinase activity (Blommaart et al., 1997) . Treatment of Hsp47 Ϫ/Ϫ cells with these inhibitors significantly enhanced the accumulation of procollagen in insoluble fractions (Figure 4A ). We also examined the effect of rapamycin, which induces autophagy by inhibiting mTor (Berger et al., 2006) . Stimulation of autophagic activity by rapamycin treatment clearly decreased the accumulation of procollagen in the insoluble fraction of Hsp47 Ϫ/Ϫ cells ( Figure 4B ). These results indicate that misfolded procollagen is eliminated through autophagy in Hsp47 Ϫ/Ϫ cells. ATG5 is an essential factor for autophagosome formation (Mizushima et al., 2001) . To examine whether depletion of the essential factor affects degradation of procollagen accumulated in the ER of Hsp47 Ϫ/Ϫ cells, endogenous ATG5 level was reduced by RNA interference (RNAi)-mediated knockdown. Specific siRNA effectively decreased levels of ATG5 mRNA ( Figure 4C ) and ATG5 protein complexed with ATG12 (Mizushima et al., 2001 ; Figure 4D ). Activation of autophagy was almost completely inhibited by ATG5 knockdown, as examined by LC3-II levels ( Figure 4E ). Under the ATG5 knockdown conditions, inhibition of autophagic activity significantly enhanced the accumulation of insoluble procollagen in Hsp47 Ϫ/Ϫ cells, but not in Hsp47 ϩ/ϩ cells ( Figure 4F ). Overexpression of an ATG4B mutant, which forms stable complex with LC3-I and efficiently inhibits autophagy-mediated degradation (Fujita et al., 2008) , also stimulated accumulation of insoluble procollagen in Hsp47 Ϫ/Ϫ cells ( Figure 4G ). These results clearly indicate that degradation of misfolded procollagen in Hsp47 Ϫ/Ϫ cells is highly dependent on autophagic activity.
To analyze whether the autophagy-mediated clearance stimulated in Hsp47 Ϫ/Ϫ occurs randomly from the ER, the level of PDI, a soluble ER protein, was examined under ATG5-knockdown conditions. In contrast to the significant increase in the intracellular procollagen level, particularly in pellet fractions ( Figure 4F ), the level of PDI was unaffected by ATG5-knockdown (Supplemental Figure S4) . BiP, which associates with unfolded/misfolded procollagen in the ER, also accumulated in the detergent-insoluble fraction with procollagen in Hsp47 Ϫ/Ϫ cells after inhibition of autophagy (Supplemental Figure S4) . Thus, degradation of insoluble procollagen would appear not to be performed by the random elimination of the ER, suggesting that some mechanism must exist for the selective clearance of the ER containing aggregated proteins. Accumulation of misfolded proteins in the ER is potentially toxic to the cell, and apoptotic cell death was previously observed in Hsp47 Ϫ/Ϫ embryos . To test whether autophagic activity contributes to cell survival under conditions that misfolded procollagens are aggregated in the ER, apoptotic cell death in Hsp47 Ϫ/Ϫ cells was determined in the presence or absence of ATG5 siRNA. Inhibition of autophagy by ATG5 knockdown significantly increased apoptotic cell death in Hsp47 Ϫ/Ϫ cells, but not in Hsp47 ϩ/ϩ cells ( Figure 5, A and B) . Under the same conditions, up-regulation of CHOP expression was observed only in Hsp47 Ϫ/Ϫ cells ( Figure 5 , C and D). Apoptotic cell death induced by ER stress is known to be mediated by up-regulation of ATF4, and this transcription factor induces CHOP expression and activation of caspase-3 and caspase-12. Thus, we examined levels of ATF4, caspase-3, and caspase-12 in Hsp47 Ϫ/Ϫ cells and confirmed that all three factors are upregulated (Ishida, Kubota, and Nagata, unpublished results) . These data suggest that ER stress caused by the accumulation of misfolded procollagen induces apoptosis via the ATF4-CHOP pathway. Taken together, these observations clearly indicate that autophagy protects cells against the toxic effects of procollagen aggregates accumulated in the ER.
Autophagy-dependent Degradation of Disease-causing Mutants of Type I Collagen
Type I collagen is composed of two pro␣1(I) chains and one pro␣2(I) chain, in which mutations cause brittle-bone diseases including OI (Marini et al., 2007) . In cells derived from OI patients, procollagen is misfolded and accumulates in the ER (Kojima et al., 1998) . However, the mechanism of degradation of these misfolded procollagen molecules is largely unknown. We therefore examined the role of autophagy in the degradation of mutant collagen using cultured Mov13 cells, in which the pro␣1 chain of type I collagen is not expressed due to a retroviral insertion in the first intron of the gene, resulting in expression of only the pro␣2(I) chain (Schnieke et al., 1983; Breindl et al., 1984) . We first examined pro␣2(I) chain degradation in Mov13 cells and found that it is degraded via the lysosomal pathway, as indicated by the effect of lysosomal inhibitors ( Figure 6A ). Proteasome inhibitors did not inhibit pro␣2(I) chain degradation in Mov13 cells, consistent with a previous report (Gotkin et al., 2004) . Because this degradation was inhibited by the treatment of cells with brefeldin A, pro␣2(I) chain in Mov13 cells is assumed to be degraded via COPII pathway. Next, we examined the involvement of autophagy in the clearance of the pro␣2(I) chain. Although the LC3-II level increased slightly in the presence of lysosomal inhibitors ( Figure 6B ), ATG5 knockdown or the overexpression of an inactive ATG4B mutant had no significant effect on pro␣2(I) chain accumulation ( Figure 6, C and D) . Thus, the pro␣2 chain of type I collagen appears to be degraded in lysosomes via an autophagy-independent pathway in Mov13 cells.
Several Mov13-derived cell lines that were stably transfected with the wild-type ␣1 chain or disease-causing mutants of type I collagen pro␣1 chains have been established (Lamande and Bateman, 1993; Fitzgerald et al., 1999) . In this study, we used three of these cell lines (Supplemental Figure  S1 ): Mov13-WT, Mov13-Arg, and Mov13-IAFS cells. In Mov13-Arg cells, Gly859 of the pro␣1(I) chain, which is located in the triple helix-forming region, is mutated to Arg. In Mov13-IAFS cells, the mutation is located in the C-propeptide region of the pro␣1(I) chain [a five-base pair deletion at the carboxy terminus, resulting in extension of the pro␣1(I) chain] and causes a defect in trimer formation. The pro␣1(I) chain of this C-propeptide mutant was reported to be degraded via the ERAD pathway (Fitzgerald et al., 1999) . We confirmed that in Mov13-WT cells, the exogenously introduced pro␣1(I) chain and the endogenous pro␣2(I) chain were correctly folded and secreted into the medium, whereas neither of the chains were secreted from Mov13-Arg or Mov13-IAFS cells (Supplemental Figure S5) , probably as a result of misfolding (Lamande and Bateman, 1993; Fitzgerald et al., 1999) .
Nonreducing SDS-PAGE followed by immunoblotting indicated that type I collagen forms trimers in Mov13-Arg cells as well as in Mov13-WT cells ( Figure 7A ). In contrast, type I collagen in Mov13-IAFS cells failed to form trimers ( Figure  7A ). We analyzed the degradation of procollagen in these cell lines using lysosome or proteasome inhibitors. Accumulation of type I collagen pro␣1 and pro␣2 chains was unaffected by the presence of proteasome or lysosome inhibitors in Mov13-WT cells ( Figure 7B , top panel, and Supplemental Figure S6A ). In Mov13-IAFS cells, inhibition of proteasome activity significantly stimulated accumulation of the pro␣1(I) chain, particularly in the supernatant fraction ( Figure 7B , middle panel, and Supplemental Figure S6A ) concomitant with the induction of polyubiquitination of the pro␣1(I) chain ( Figure 7C ). These results confirm that the pro␣1(I) chain is degraded by ERAD in the timer formationdeficient cells. The accumulation of the pro␣2(I) chain in the insoluble fractions of Mov13-IAFS cells increased in the presence of lysosome inhibitors, but not in the presence of proteasome inhibitors ( Figure 7B , middle panel, and Supplemental Figure S6A ). These results are consistent with the data from untransfected Mov13 cells (Figure 6 ), and are reasonable because the pro␣1(I) and pro␣2 (I) chains cannot form timers in Mov13-IAFS cells because of the pro␣1(I) chain mutation in the trimer-forming C-propeptide region.
In contrast, both the pro␣1(I) and pro␣2(I) chains in Mov13-Arg cells are accumulated in insoluble fractions after treatment with lysosome inhibitors, whereas such accumulation was not observed by the treatment with proteasome inhibitors ( Figure 7B , bottom panel, and Supplemental Figure S6A ). These data suggest that, when misfolded procollagen molecules form trimers as was also seen in Hsp47 Ϫ/Ϫ cells, they cannot be eliminated by ERAD, but by autophagy-lysosome system (Figures 1 and 4) . In the presence of lysosome inhibitors, the LC3-II level in Mov13-Arg cells was more than fivefold greater relative to that in Mov13-WT cells (Supplemental Figure S6B) , indicating that autophagy is induced in Mov13-Arg cells. LC3-II level was not increased by the presence of lysosome inhibitors in Mov13-IAFS cells, consistent with the degradation of this mutant of the pro␣1(I) chain via ERAD.
We also examined the accumulation of pro␣1(I) chains in the three Mov13-derived cell lines under ATG5 knockdown conditions. Depletion of ATG5 significantly enhanced accumulation of the pro␣1(I) and pro␣2(I) chains in insoluble fractions in Mov13-Arg cells, in which the ␣1 and ␣2 chains form misfolded trimers ( Figure 7D , right panels, and Supplemental Figure S6C ). In contrast, levels of the pro␣1(I) and pro␣2(I) chains were unaffected by ATG5 knockdown in Mov13-WT and Mov13-IAFS cells ( Figure 7D , left and middle panels, and Supplemental Figure S6C ). In the presence of bafilomycin A1, trimeric procollagens accumulated mainly in the insoluble fractions of Mov13-Arg cells as analyzed by nonreducing SDS-PAGE followed by Western blot analysis, suggesting that insoluble procollagen aggregates are mainly composed of misfolded trimeric procollagen instead of misfolded monomeric procollagen ( Figure 7E ). These results thus support the notion that the endogenous autophagic activity is essential for the clearance of ERAD-ineffective aggregates of trimeric procollagen from the ER.
We finally tested whether the ERAD of soluble misfolded proteins is affected by the presence of misfolded procollagen aggregates, which are being eliminated by autophagy from the ER. Mov13-Arg cells were transfected with the NHK variant of ␣1-antitrypsin, a well-known ERAD substrate (Liu et al., 1999) , and degradation of NHK through ERAD was examined by pulse-chase experiments. The degradation of NHK was unaffected by the presence of ATG5 siRNA (Figure 8A) . In contrast, lactacystin clearly inhibited the degradation of NHK both in ATG5 siRNA-treated and untreated cells ( Figure 8B ). These results clearly demonstrated that the elimination of soluble misfolded protein via ERAD and insoluble misfolded protein via autophagy occurs simultaneously and independently within the same cell, and suggest that the autophagy-dependent aggregate elimination system may mainly use factors unrelated to ERAD although detailed mechanisms remain to be investigated.
DISCUSSION
We previously reported using Hsp47-disrupted mouse embryos and cultured cells that type I and type IV procollagens accumulate in the ER due to inability to form properly folded triple helix (Nagai et al., 2000; Marutani et al., 2004; Matsuoka et al., 2004; Ishida et al., 2006) . In these embryos and cells, detergent-insoluble procollagens are accumulated in the ER. Thus, the Hsp47-null cells were adopted as a useful model to analyze the fate of aggregated procollagens without genetic mutations (Figures 1-5 ). In addition, we used Mov13-derived cell lines as models for improperly assembled/folded procollagen because of the genetic mutations (Figures 6 and 7) . Type I collagen is a trimer of two ␣1 chains and one ␣2 chain. In Mov13 cells, which lacks collagen pro␣1(I) chain expression (Schnieke et al., 1983; Breindl et al., 1984) , the pro␣2(I) chain is rapidly degraded by the lysosome (Gotkin et al., 2004) , which was confirmed in the present study. By reintroducing normal or mutant pro␣1(I) chains into Mov13 cells, the assembly (trimer formation) and triple helix formation of the ␣ chains can be analyzed. The transfected wild-type pro␣1(I) chain and endogenous pro␣2(I) chain in Mov13-WT cells make properly folded trimers and the procollagen is secreted into the medium. The pro␣1(I) chain in Mov13-IAFS cells cannot make trimers with the endogenous pro␣2(I) chain because of the mutation in the trimer-forming region, and the ␣1 chain in Mov13-Arg cells makes an improperly folded trimer. In Mov13-IAFS cells, each pro␣ chain accumulates as a monomer, whereas procollagen in Mov13-Arg cells was shown to accumulate in the ER as a detergent-insoluble aggregate, which is similar to that produced in Hsp47 Ϫ/Ϫ cells without any mutations in the collagen genes. Using these four cell lines, we have determined the fate of each ␣ chain.
Mutations in type I collagen genes are tightly associated with OI (Millington-Ward et al., 2005) . The OI-causing G859R mutation used in the present study (Mov13-Arg) is located in the triple helical domain. This mutant pro␣1(I) chain accumulated in the ER as detergent-insoluble aggregates that were removed by autophagic degradation. In fact, there are only a few mutations known in the C-propeptide that would result in failed assembly. The vast majority of OI mutations are in the helix-forming region, and the mechanism of degradation for these mutations has never been established. To explore therapeutic strategies for collagenrelated diseases for which no effective therapies are currently available, it will be important to determine the fate of the misfolded procollagens in vivo, such as type I collagen in OI, type II collagen in chondrodysplasias, and type III collagen in Ehlers-Danlos syndrome.
In the present study, we found that misfolded procollagens in Hsp47 Ϫ/Ϫ and Mov13-Arg cells were degraded in the lysosome via an autophagic pathway, but not via the ERAD pathway (Figures 1-5 and 7) . Autophagy is essential for degrading aggregated procollagen as indicated by the use of specific inhibitors and RNAi-mediated knockdown. Consistently, elimination of aggregated procollagen was enhanced by activating autophagic activity with rapamycin. We also showed that inhibition of autophagic activity significantly reduced cell viability in Hsp47 Ϫ/Ϫ cells ( Figure 5 ), indicating that autophagy plays an essential role in cell survival by removing ERAD-ineffective misfolded procollagen species from the ER. These observations are consistent with the fact that autophagy has a cell protective effect against ER stressors (Ogata et al., 2006) . In contrast, the pro␣1(I) chain in Mov13-IAFS cells cannot form a trimer with the endogenous pro␣2(I) chain, and the pro␣1(I) chain monomer was degraded via ERAD. These observations indicate that aggregated procollagen trimers are degraded by the autophagylysosome pathway, whereas misfolded monomer pro␣1 chains are degraded through ERAD (Figure 9 ). Using these unique systems where monomeric or trimeric misfolded procollagen ␣ chains can be selectively forced to accumulate in the ER, we have established that the elimination of misfolded proteins by autophagy or ERAD is dictated by whether their accumulated forms adopt multimeric or monomeric forms. Our present study strongly supports the previous observation that soluble human the ␣-antitrypsin Z variant (ATZ) is destined for clearance by ERAD, whereas aggregated ATZ is destined for autophagic clearance (Kruse et al., 2006) . It is worthwhile to note that this partitioning system is conserved from yeasts to mammals. Intriguingly, the pro␣2(I) chain in Mov13 cells is not degraded through ERAD or autophagy, but by lysosomes via an autophagy-independent pathway (Figure 6 ). The pro␣2(I) chain in Mov13 cells is transported to the Golgi apparatus before being degraded in the lysosome (Gotkin et al., 2004) , which may suggest the existence of additional components responsible for discriminating misfolded procollagens. However, detailed mechanisms for the third degradation pathway remain to be investigated.
A key question is how the accumulation of aggregationprone misfolded proteins within the ER triggers autophagy, which is exclusively a cytoplasmic phenomenon. Bernales et al. (2006) suggested that ER expansion induced by ER stress could trigger digestion of the ER via autophagy in yeast (Bernales et al., 2006) . ER stress was also reported to induce expression of key components required for autophagy in yeast and mammalian cells (Ogata et al., 2006; Yorimitsu et al., 2006) . In Hsp47 Ϫ/Ϫ cells, we observed dilation of the ER by immunoelectron microscopy Ishida et al., 2006) and induction of the spliced XBP-1 (Ishida, Kubota, and Nagata, unpublished results), indicating activation of the ER stress response. At the same time, the activation of LC3-II was also observed in Hsp47 Ϫ/Ϫ cells (Figure 3) . Thus, ER stress may be an important inducer of autophagic degradation of ER proteins, including aggregated procollagen, although further investigation is needed to clarify the exact links between ER stress and autophagy. A model for the degradation of misfolded procollagen molecules in the ER. Type I collagen trimers that contain the misfolded pro␣1(I) chain due to chaperone-disruption or genetic mutation accumulate as aggregates in the ER. These aggregates are eliminated by an autophagy-lysosome pathway, but not by ERAD. In contrast, mutant type I collagen pro␣1 chain that is deficient in trimer formation is eliminated by the ERAD pathway. In addition, misfolded protein (NHK) and misfolded procollagens are degraded independently by ERAD or autophagy, respectively, in the same cell. Red stars indicate mutated amino acids.
We examined whether misfolded procollagen accumulated in the ER inhibit ERAD activity by coexpressing the ERAD substrate, NHK, in Mov13-Arg cells where procollagen is degraded through autophagy. We found that NHK is degraded by ERAD even when autophagy is blocked by treating the cells with ATG5 siRNA and that the degradation of NHK was totally inhibited by treatment of the cells with the proteasome inhibitor lactacystin in the presence or absence of siRNA treatment (Figures 8). These results suggest not only that ERAD and autophagy exert their degradative activity independently, but also that there exists some mechanism to discriminate among misfolded proteins in the ER and determine their processing either by ERAD or autophagy. Our experiments here suggest that the molecular conformation, and, in particular, the tendency to form aggregates, may determine which degradation pathway is used.
Whether autophagy engulfs and degrades the ER selectively or nonselectively is also a crucial question. In the ER of Hsp47 Ϫ/Ϫ cells, the ER-resident molecular chaperone BiP bound procollagen, accumulated in the detergent-insoluble fraction, and was degraded through autophagy (Supplemental Figure S4 ). Although accumulation of misfolded collagen trimers was significantly stimulated by inhibition of autophagy by RNAi-mediated knockdown particularly in insoluble fractions (Figure 4 , A, F, and G), this inhibition did not affect the level of PDI, a soluble protein in the ER (Supplemental Figure S4 ). These observations suggest a possible mechanism where aggregate-containing regions of the ER are selectively eliminated by autophagy, and this possibility remains to be investigated in the future.
